Skip to main content

Remote Job Finders (RJF)

Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy

Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with Parkinson’s disease. Phase 1b/2a data showed that the asset can improve motor function and mobility in patients.

Biopharma Could Provide a Haven for Investment as Middle East Conflict Roils Global Markets

Biotech, in particular companies that are pre-commercial with a longer-duration risk profile, could be great investments as Operation Epic Fury rolls on, according to a Truist Securities analysis.
Scroll to top